The Food and Drug Administration (FDA) isn’t the only government regulatory body cracking down on fraud and other misconduct in the pharmaceutical industry. According to a recent speech by Securities & Exchange Commission (SEC) Enforcement Director Andrew Ceresney, pharmaceutical companies must also contend with the primary federal securities regulator if their financial dealings are...
Read more
